Salud Pública y Materno-Infantil
Departamento
Radboud University Nijmegen
Nimega, HolandaPublicaciones en colaboración con investigadores/as de Radboud University Nijmegen (4)
2021
-
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
BMC infectious diseases, Vol. 21, Núm. 1, pp. 5
2019
-
Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study
Scandinavian Journal of Immunology, Vol. 89, Núm. 6
2014
-
The PedPAD study: Boys predominate in the hypogammaglobulinaemia registry of the ESID online database
Clinical and Experimental Immunology, Vol. 176, Núm. 3, pp. 387-393
2012
-
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: Application of individualized therapy in HIV-infected infants and toddlers
British Journal of Clinical Pharmacology, Vol. 73, Núm. 4, pp. 641-650